Brought to you by 
Series A for GlycoVaxyn leads to CHF11.5mm
18 Jul 2007
Executive Summary
GlycoVaxyn AG (developing conjugated vaccines) raised CHF11.5mm ($9.57mm) in its Series A financing round to seed investors Sofinnova Partners and Index Ventures.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Biotechnology
- Synthesis Technologies, Production Processes
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com